FDA Archives - PsychPartners

Stimulant Misuse Is Declining

ADHD Child Psychiatry Cocaine Medications Research Stimulants Substance Use

Stimulant Misuse Is Declining

June 9, 2026by Chris Aiken, MD0

One Med Stands Out in Re-Analysis of Cocaine Use Disorder

Addiction Meds Cocaine Medications Methamphetamine Research Substance Use Top Research

One Med Stands Out in Re-Analysis of Cocaine Use Disorder

June 8, 2026by Chris Aiken, MD0

FDA Clears a New Type of TMS for PTSD

Devices Disorders Neuromodulation/TMS PTSD Research Research for the Public Top Research

FDA Clears a New Type of TMS for PTSD

June 7, 2026by Chris Aiken, MD0

FDA Moves the Goalposts on Alcohol Treatment

Addiction Meds Alcohol Research Substance Use

FDA Moves the Goalposts on Alcohol Treatment

June 2, 2026by Chris Aiken, MD0

At-Home Device Approved for PTSD

Devices Disorders Neuromodulation/TMS PTSD Research Research for the Public Top Research

At-Home Device Approved for PTSD

May 28, 2026by Chris Aiken, MD0

Atomoxetine Combo for Sleep Apnea

Medications Research Sleep Top Research

Atomoxetine Combo for Sleep Apnea

May 21, 2026by Chris Aiken, MD0

Leucovorin Scripts Surge in Autism

Autism Child Psychiatry Medications Research

Leucovorin Scripts Surge in Autism

May 20, 2026by Chris Aiken, MD0

CBT Helps Sustain Esketamine

Depression Difficult to Treat Depression Ketamine Research Therapy Top Research

CBT Helps Sustain Esketamine

May 7, 2026by Chris Aiken, MD0

A GLP-1 Trial Changes the Score in Alcohol

Alcohol GLP1 Agonists Medications Research Research for the Public Substance Use Top Research

A GLP-1 Trial Changes the Score in Alcohol

May 5, 2026by Chris Aiken, MD0

FDA Approves At-Home tDCS — But Should It Have?

Depression Neuromodulation/TMS Research

FDA Approves At-Home tDCS — But Should It Have?

April 25, 2026by Chris Aiken, MD2

Censorship, Bias, and Autism

Autism Research Supplements

Censorship, Bias, and Autism

April 10, 2026by Chris Aiken, MD0

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

Antipsychotics Bipolar Meds Research Schizophrenia and Psychosis Top Research

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

March 30, 2026by Chris Aiken, MD3

Flow: At-home tDCS Approved for Depression

Depression Neuromodulation/TMS Research Research for the Public Top Research

Flow: At-home tDCS Approved for Depression

March 17, 2026by Chris Aiken, MD0

A Wearable Headset for Difficult-to-Treat Depression

Depression Devices Difficult to Treat Depression Neuromodulation/TMS Research Research for the Public Top Research

A Wearable Headset for Difficult-to-Treat Depression

March 15, 2026by Chris Aiken, MD0

Two GLP-1 Agonists Fail in Dementia

Dementia GLP1 Agonists Research Top Research

Two GLP-1 Agonists Fail in Dementia

January 25, 2026by Chris Aiken, MD0

Brexpiprazole (Rexulti) in PTSD

Antipsychotics Medications PTSD Research Top Research

Brexpiprazole (Rexulti) in PTSD

September 21, 2025by Chris Aiken, MD0

Guanfacine for Aggression in Prader-Willi Syndrome

Child Psychiatry Medications Research Top Research

Guanfacine for Aggression in Prader-Willi Syndrome

May 21, 2025by Chris Aiken, MD0